0 followers
Olaris aims to fundamentally change how diseases are diagnosed and treated. With their pioneering metabolomics platform and machine learning algorithms, they produce personalized “Biomarkers of Response” (BoR) to readily differentiate drug responders (R) from non-responders (NR).
Elizabeth O'Day
Watchmaker Genomics
3 followers
Hillevax
2 followers
Kyverna Therapeutics
6 followers
QurAlis
1 follower
Cue Biopharma
1 follower
Ultima Genomics
3 followers
Cellares
2 followers
Arbor Biotechnologies
2 followers
Trevi Therapeutics
1 follower
Thermo Fisher Scientific
173 followers
Genentech
158 followers
Explore companies